Coagulation Cost per Reportable Result (CPRR), Equipment and Reagents
Closed Special Notice Posted
- Solicitation number
- HT940825QE0010
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Biloxi, Mississippi 39534, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency's Healthcare Contracting Division - South in San Antonio, Texas has published a Special Notice announcing its intent to award a sole source contract to Diagnostica Stago of Parsippany, New Jersey for coagulation testing services at Keesler Medical Center, Keesler Air Force Base, Mississippi. The contract will be structured as a firm-fixed-price Cost-per-Reportable-Result arrangement under which the contractor will provide all necessary equipment, consumables, and services for coagulation testing. The intended award falls under the NAICS code 325413 for In-Vitro Diagnostics Substance Manufacturing with a small business size standard of 1,250 employees, though Diagnostica Stago is classified as an "other-than-small business." The contract performance period is scheduled from October 1, 2025 through March 31, 2026, with two additional two-month option periods available. This procurement will be executed under the authority of Federal Acquisition Regulation 13.106-1(b) with an award planned by October 1, 2025.
The purpose of this Special Notice is to inform potential sources that while the agency intends a sole source award, it will consider capability statements from other responsible sources who believe they can perform the required work. Interested contractors must submit their capability statements by September 12, 2025, and are responsible for marking any proprietary information appropriately. To be considered as an alternative source, contractors must demonstrate three critical capabilities: the ability to provide the required coagulation testing, the capacity to deliver, install, and validate analyzers to ensure patient-ready testing by October 1, 2025, and the technical ability to connect to the Defense Health Agency/Military Health System network. The government will not reimburse interested sources for any information provided, will not conduct capability briefings, and will not accept telephonic inquiries regarding this opportunity.
Notice text
The Healthcare Contracting Division – South (HCD-S), San Antonio, Texas, intends to award a firm-fixed-price (FFP) sole source contract to Diagnostica Stago of Parsippany, New Jersey to conduct Coagulation testing for Keesler Medical Center, Keesler Air Force Base, Mississippi. As a Cost-per-Reportable-Result (CPRR) vehicle, the contractor also provides all equipment, consumables, and services necessary to perform the required testing. The contract will be awarded under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b). The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostics Substance Manufacturing. The Small Business Size Standard is 1,250 employees. Diagnostica Stago is an "other-than-small business." The contract will be awarded on or before 1 October 2025.
NOTE: This contract will be issued for a performance period of 1 October 2025 -31 March 2026, with two (2) two-month option period.
This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date to determine if any other entity is capable of performing the required testing. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. In order for the Government to consider another source, the capability statement must demonstrate the source's ability to 1) provide the required testing; 2) deliver, install, and validate the analyzer(s) to ensure patient-ready testing by 01 October 2025; and 3) ability to connect to the Defense Health Agency/Military Health System network.
The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government.
NOTE: INTERESTED VENDORS MUST RESPOND TO THIS NOTICE TO THE BELOW POCs ON OR BEFORE 12 SEPTEMBER 2025 BY 10 AM CENTRAL TIME IN ORDER TO BE CONSIDERED.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity